Cannabis Products: FDA Asks Dosing, Research Incentive Questions

 
• By Derrick Gingery

The public hearing on cannabis and cannabis-derivative products also included calls for Good Manufacturing Practices to be imposed.

a series of CBD oil bottle isolated on white
FDA asked during a public hearing on cannabis products whether patients taking unapproved cannabis products were monitored for adverse events. • Source: Shutterstock

More from Product Reviews

More from Pink Sheet